TY - JOUR
T1 - Mechanisms of BDNF regulation in asthmatic airway smooth muscle
AU - Aravamudan, Bharathi
AU - Thompson, Michael A.
AU - Pabelick, Christina M.
AU - Prakash, Y. S.
N1 - Funding Information:
This article was supported by grants from the National Institutes of Health(NIH) (R01 HL-088029 and R01 HL-056470) to Y. S. Prakash, and by a Young Clinical Scientist Award from the Flight Attendants Medical Research Institute to B. Aravamudan.
Publisher Copyright:
© 2016 the American Physiological Society.
PY - 2016/8/1
Y1 - 2016/8/1
N2 - Brainderived neurotrophic factor (BDNF), a neurotrophin produced by airway smooth muscle (ASM), enhances inflammation effects on airway contractility, supporting the idea that locally produced growth factors influence airway diseases such as asthma. We endeavored to dissect intrinsic mechanisms regulating endogenous, as well as inflammation (TNF-α)-induced BDNF secretion in ASM of nonasthmatic vs. asthmatic humans. We focused on specific Ca2+ regulationand inflammation-related signaling cascades and quantified BDNF secretion. We find that TNF-α enhances BDNF release by ASM cells, via several mechanisms relevant to asthma, including transient receptor potential channels TRPC3 and TRPC6 (but not TRPC1), ERK 1/2, PI3K, PLC, and PKC cascades, Rho kinase, and transcription factors cAMP response element binding protein and nuclear factor of activated T cells. Basal BDNF expression and secretion are elevated in asthmatic ASM and increase further with TNF-α exposure, involving many of these regulatory mechanisms. We conclude that airway BDNF secretion is regulated at multiple levels, providing a basis for autocrine effects of BDNF under conditions of inflammation and disease, with potential downstream influences on contractility and remodeling.
AB - Brainderived neurotrophic factor (BDNF), a neurotrophin produced by airway smooth muscle (ASM), enhances inflammation effects on airway contractility, supporting the idea that locally produced growth factors influence airway diseases such as asthma. We endeavored to dissect intrinsic mechanisms regulating endogenous, as well as inflammation (TNF-α)-induced BDNF secretion in ASM of nonasthmatic vs. asthmatic humans. We focused on specific Ca2+ regulationand inflammation-related signaling cascades and quantified BDNF secretion. We find that TNF-α enhances BDNF release by ASM cells, via several mechanisms relevant to asthma, including transient receptor potential channels TRPC3 and TRPC6 (but not TRPC1), ERK 1/2, PI3K, PLC, and PKC cascades, Rho kinase, and transcription factors cAMP response element binding protein and nuclear factor of activated T cells. Basal BDNF expression and secretion are elevated in asthmatic ASM and increase further with TNF-α exposure, involving many of these regulatory mechanisms. We conclude that airway BDNF secretion is regulated at multiple levels, providing a basis for autocrine effects of BDNF under conditions of inflammation and disease, with potential downstream influences on contractility and remodeling.
KW - Airway
KW - Asthma
KW - Brain-derived neurotrophic factor
KW - Inflammation
KW - Neurotrophin
KW - Secretion
UR - http://www.scopus.com/inward/record.url?scp=84983735413&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84983735413&partnerID=8YFLogxK
U2 - 10.1152/ajplung.00414.2015
DO - 10.1152/ajplung.00414.2015
M3 - Article
C2 - 27317689
AN - SCOPUS:84983735413
SN - 1040-0605
VL - 311
SP - 270
EP - 279
JO - American Journal of Physiology
JF - American Journal of Physiology
IS - 2
ER -